"Tech-Histories Alive" on January 21 with Prof. Christian Peschel
A life’s work for stem cell research
Today blood stem cells are frequently used in therapy to treat leukemia and lymphoma. But decades of research were necessary before the first successful applications in treatment. On January 21 in the series "Tech-Histories Alive", Prof. Christian Peschel will take a look at the decisive steps in researching stem cell biology, exploring the path to successful application and potentials for further stem cell therapies.
Outstanding personalities are the life’s blood of science. What motivates them? What have they experienced? What thoughts and ideas do they want to pass on to others? "Tech-Histories Alive" spotlights the answers to these questions from outstanding retired scientists appointed by TUM as Emeriti of Excellence.
Prof. Christian Peschel held the Chair of Hematology and Internal Oncology and was Director of the III. Medical Clinic of TUM’s Klinikum rechts der Isar from 1997 until his retirement in 2017. Before that he held positions at the university hospitals in Mainz and Innsbruck and conducted research at the Laboratory of Immunology of the National Institutes of Health (NIH) in the USA. Peschel has been a member of numerous professional societies and advisory bodies, including the Central Commission for Somatic Gene Therapy of the German Medical Association.
TUM’s Munich Center for Technology in Society co-organizes "Tech-Histories Alive". The center conducts research, teaches and promotes public dialog on the mutual interactions of science, technology and society.
Tech-Histories Alive Prof. Christian Peschel: "Stammzellen als therapeutisches Prinzip. Chancen und Herausforderungen" ("Stem Cells as a Therapeutic Principle. Opportunities and Challenges")
Tuesday, January 21, 2020, 6:30 pm
Technical University of Munich (TUM) Vorhoelzer Forum Arcisstr. 21
Stem cell transplants can save lives, for example in patients with leukemia. However, these treatments are not free of risks. One complication that may occur is graft-versus-host disease (GVHD), basically donor-derived...
Stem cells have two important capabilities: they can develop into a wide range of cell types and simultaneously renew themselves, creating fresh stem cells. Using a model of the blood forming (hematopoietic) system,...
Researchers in Germany and the U.S. have proven for the first time that specific individual cells of the immune system, termed central memory T cells, have all the essential characteristics of adult tissue stem cells. Such...